Spinal Biologics in Minimally Invasive Lumbar Surgery

Abstract EN

As the use of minimally invasive spine (MIS) fusion approaches continues to grow, increased scrutiny is being placed on its outcomes and efficacies against traditional open fusion surgeries.

While there are many factors that contribute to the success of achieving spinal arthrodesis, selecting the optimal fusion biologic remains a top priority.

With an ever-expanding market of bone graft substitutes, it is important to evaluate each of their use as it pertains to MIS techniques.

This review will summarize the important characteristics and properties of various spinal biologics used in minimally invasive lumbar surgeries and compare their fusion rates via a systematic review of published literature.